Figure 11.
Engineered EVs for immunotherapy. a) Schematic representation of EXO‐OVA‐mAb targeting lymph nodes and enhancing tumor‐specific T cell responses. Reproduced with permission.[ 163 ] Copyright 2020, Elsevier. ILN: inguinal lymph nodes. b) Schematic diagram of the construction of MUC1‐Dex. Reproduced with permission.[ 164 ] Copyright 2021, Elsevier.